$0Q4U Novonesis, formed from the merger of Novozymes and Chr. Hansen, is a Danish biotech leader using microbes and enzymes to improve products in food, cleaning, and biofuels while driving sustainability. The company custom-produces biological “cocktails” that enhance efficiency and reduce waste, operating in a $60 billion biosolutions market and expanding into the trillion-dollar specialty chemicals sector.
With high single-digit growth, strong customer retention, and 10% of revenue invested in R&D, it leverages AI to accelerate innovation in areas like plastic recycling and carbon capture. Regulatory delays remain the main obstacle, but faster approvals could unlock major environmental and economic gains. Rooted in Denmark’s fermentation heritage and a purpose-driven culture, Novonesis blends profitability with environmental impact, proving that biology can effectively replace traditional chemistry in everyday industries.
With high single-digit growth, strong customer retention, and 10% of revenue invested in R&D, it leverages AI to accelerate innovation in areas like plastic recycling and carbon capture. Regulatory delays remain the main obstacle, but faster approvals could unlock major environmental and economic gains. Rooted in Denmark’s fermentation heritage and a purpose-driven culture, Novonesis blends profitability with environmental impact, proving that biology can effectively replace traditional chemistry in everyday industries.
